Feb 14 (Reuters) - Opthea Ltd (OPT) :
- OPTHEA LTD- COMPLETES ENROLLMENT IN FIRST TRIAL WITH SOZINIBERCEPT
- OPTHEA LTD- ENROLLMENT OF SECOND PIVOTAL TRIAL TO COMPLETE IN CALENDAR Q2 2024
- OPTHEA LTD- POSITIVE RESULTS FROM PHASE 2B STUDY OF SOZINIBERCEPT MET PRE-SPECIFIED PRIMARY EFFICACY ENDPOINT
- OPTHEA LTD- SECONDARY OUTCOMES WERE POSITIVE FOR COMBINATION THERAPY WITH SOZINIBERCEPT
- OPTHEA LTD- TOP-LINE RESULTS FROM TWO PHASE 3 PIVOTAL TRIALS, COAST AND SHORE, EXPECTED BY MID-2025
News: OPT Opthea Completes Enrollment In First Trial With Sozinibercept
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $245.2M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.5¢ | $357.0K | 960.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 202944 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 1490 | 1 |
View Market Depth
| Last trade - 16.10pm 18/06/2024 (20 minute delay) ? |
| OPT (ASX) Chart |